Investor Relations

Group Companies

ASCENSIA

LSI Meduence

Wemex

mediford

Epredia

PHCbi

PHC IVD

Ascensia Diabetes Care Holdings AG

Ascensia Diabetes Care Holdings AG is a global diabetes technology company focused on providing solutions that help people with diabetes. The company markets glucose monitoring systems, testing supplies and digital diabetes management solutions in more than 100 countries.

Learn More

LSI Medience Corporation

LSI Medience Corporation provides medical support services mainly in Japan by fusing medical care with science. Our total solutions in high-quality clinical testing contribute to the prevention and early detection of illnesses as well as effective treatment.

Learn More

WEMEX

WEMEX provides solutions that drive digital transformation in healthcare to clinics, hospitals, and pharmacies in Japan. These include an electronic medical record system that interfaces with online eligibility verification and e-prescriptions, support tools for pharmacy management and specific health guidance, and telemedicine systems, etc.

Learn More (Japanese website)

Mediford

Mediford offers services that support a wide range of drug research and development, from the exploratory phase to clinical testing, using the testing expertise and experience in advanced analysis accumulated through established businesses in clinical trials and non-clinical testing.

Learn More

Epredia Holdings Ltd.

Epredia Holdings Ltd. is a global anatomical pathology company, providing a comprehensive range of solutions for precision cancer diagnostics. The company provides a range products to support pathologists and researchers, including instruments, microscope slides, consumables and dyeing reagents.

Learn More

PHCbi

PHCbi develops and manufactures innovative equipment and services for various aspects of scientific research conducted in medical institutions, universities and pharmaceutical companies. Key products include sample preservation, cell culture and clean research environments.

Learn More

PHC IVD

PHC IVD has years of history in contributing to medical care, providing excellence in medical devices and in vitro diagnostics, which includes development of Japan’s first clinical diagnostic reagent in 1962 and the industry’s first auto sample fill blood glucose sensing system for blood glucose monitoring system in 1991.

Learn More